Demand for Male Infertility and Impact of COVID-19……..



The global male infertility market size is expected to reach USD 5.03 billion by 2027, expanding at a CAGR of 4.7% over the forecast period, according to a new report by Grand View Research, Inc. Advancements in diagnostic tests and increasing infertility in males are some of the major factors driving the market for male infertility. In addition, lifestyle-associated diseases causing infertility, rising obesity, and growing aging population are likely to boost the market growth during the forecast period. In U.S., one-third of infertility cases are due to female factors, one third due to male factors, and the remaining one third is unknown.
DNA fragmentation technique emerged the largest test segment in the market in 2020 and is expected to maintain its lead during the forecast period. Increasing adoption in developed countries and high cost due to higher sensitivity and reliable analysis of sperm DNA integrity are the key factors driving the segment.
On the basis of treatment, the Assisted Reproductive Technology (ART) and Varicocele Surgery segment dominated the market for male infertility in 2020 due to its high success rate. Intracytoplasmic sperm injection (ICSI) and in vitro fertilization (IVF) are the most commonly used ARTs. Medications include hormonal therapy and corticosteroids, however they are effective in very few cases.
Partnerships and agreements among key manufacturers are expected to boost the market growth in the coming years. For instance, in July 2020, Vitrolife entered into a collaboration with Prime Tech for the development and exclusive marketing of the Piezo technique, for improved Intracytoplasmic Sperm Injection (ICSI) procedure in human IVF globally except Malaysia, Thailand, and Japan. Additionally, Vitrolife will initiate the regulatory approval procedures in various markets for the future commercialization of the technology.
To Request Sample Copy of this report, click the link:
Further key findings from the study suggest:
·         Based on test, DNA fragmentation technique dominated the market in 2020 and is estimated to witness significant growth over the forecast period
·         Oxidative stress analysis test is gaining popularity due to the accurate determination of reactive oxygen species. In March 2018, Aytu BioScience, Inc. received registration from COFEPRIS in Mexico for MiOXSYS System, which is used for diagnosing male infertility
·         Europe dominated the male infertility market in 2020 and is expected to maintain its lead during the forecast period due to high adoption of costlier treatment, strong diagnosis rate, and increased awareness
·         Asia Pacific is projected to witness substantial growth over the forecast period owing to increasing investment by several clinics and pharmaceutical companies and growing healthcare expenditure
·         Some key players of the market are Bayer Healthcare, Inc.; EMD Sereno; Aytu BioScience, Inc.; Halotech DNA SL; Intas Pharmaceuticals Ltd.; Cadila Healthcare Ltd.; Andrology Solutions; and SCSA diagnostics, Inc.
The global male infertility market size was valued at USD 3.5 billion in 2020 and is estimated to expand at a CAGR of around 4.7% over the forecast period. Increasing infertility rate across the globe and adoption of assisted reproductive technologies (ARTs) are expected to be drive the market for male infertility in the forthcoming years.
ARTs cover a wide spectrum of infertility treatments and offer solutions for males facing problems, such as low sperm count, abnormal sperm quality, and poor motility. Moreover, ARTs offer a high success rate as compared to the medications. The market for male infertility is expected to witness significant growth in future owing to technological advancements in the field of assisted reproductive technologies.
Increase in the global prevalence of infertility is a significant clinical problem. Around 8% to 12% of couples have to deal with the problem of infertility worldwide. Of all cases, about 40% to 50% of cases is due to male factor infertility. This may be due to one or combination of factors, such as abnormal morphology, lower sperm concentration, and poor sperm motility. Hence, increasing male infertility and growing awareness about the same have further prompted the use of drugs, hormonal therapy, and ART.
Alcohol intake, smoking, obesity, stress, and lifestyle changes are the some of the major factors that can be attributed to infertility in males. According to the National Center for Health Statistics, the fertility rate in males below 30 years has decreased globally by 15% from 2006 to 2010.
Continuous efforts in R&D are carried out for a better understanding of the idiopathic world of infertility. Hence, companies are investing in the development of devices for identifying the root cause and targeted treatment. Furthermore, development and commercialization of hormonal therapy is likely to drive the market for male infertility during the forecast period.
Have any Query? Ask our Experts:
Grand View Research has segmented the global male infertility market based on test, treatment,:
Male Infertility Test Outlook (Revenue, USD Million, 2015 - 2027)
·         DNA Fragmentation Technique
·         Oxidative Stress Analysis
·         Microscopic Examination
·         Sperm Agglutination
·         Computer Assisted Semen Analysis
·         Sperm Penetration Assay
·         Others
Male Infertility Treatment Outlook (Revenue, USD Million, 2015 - 2027)
·         Assisted Reproductive Technology and Varicocele Surgery
·         Medication
About Grand View Research
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.



Comments

Popular posts from this blog

Foot Orthotic Insoles Market 2026: What Will Be Changes In Investment Ratio With Opportunity Analysis?? |Grand View Research, Inc.

A Look into Smokehouse Industry……Deep Analysis…..

A Look into Shapewear Industry……Deep Analysis…..